NCT06350305View on ClinicalTrials.gov

Screening for High-risk Chronic Obstructive Pulmonary Disease

Not yet recruitingOBSERVATIONAL
Enrollment

3,600

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

April 30, 2027

Study Completion Date

October 31, 2027

Conditions
High-risk COPD
Interventions
OTHER

questionnaire survey

subjects fill out questionnaires

Trial Locations (1)

450000

The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou

All Listed Sponsors
lead

Henan University of Traditional Chinese Medicine

OTHER

NCT06350305 - Screening for High-risk Chronic Obstructive Pulmonary Disease | Biotech Hunter | Biotech Hunter